Show simple item record

Thiophenes as phenyl bio-isosteres: Application in radiopharmaceutical design--I. Dopamine uptake antagonists

dc.contributor.authorKilbourn, Michael R.en_US
dc.date.accessioned2006-04-07T20:59:59Z
dc.date.available2006-04-07T20:59:59Z
dc.date.issued1989en_US
dc.identifier.citationKilbourn, Michael R. (1989)."Thiophenes as phenyl bio-isosteres: Application in radiopharmaceutical design--I. Dopamine uptake antagonists." International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology 16(7): 681-686. <http://hdl.handle.net/2027.42/28222>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B7GH9-4D4KGWH-14/2/2611f59e967fe996a5e5c9c4daf98186en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/28222
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2613523&dopt=citationen_US
dc.description.abstractPossible applications of thiophenes in radiopharmaceutical chemistry have been explored. Thiophene for benzene ring substitution was applied to the synthesis of thienyl-[18F]GBR 13119, an analog of the potent and selective dopamine uptake inhibitor [18F]GBR 13119. In vivo regional brain distribution in mice shows essentially identical results for the thienyl and phenyl compounds (striatum/cerebellum ratios of 4 at 60 min), suggesting successful substitution by the thiophene ring. The extension of this concept to the synthesis of no-carrier-added, high specific activity [18F]fluorothiophenes was examined: 5-[18F]fluoro-2-2-thiophene carboxaldehyde was prepared in 10-20% yields by an unprecedented [18F]fluoride-for-bromo substitution of 5-bromo-2-thiophenecarboxaldehyde. The possible advantages of thiophenes (lower log P, altered metabolism) in radiopharmaceutical chemistry are discussed.en_US
dc.format.extent633399 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleThiophenes as phenyl bio-isosteres: Application in radiopharmaceutical design--I. Dopamine uptake antagonistsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPhysicsen_US
dc.subject.hlbsecondlevelNuclear Engineering and Radiological Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelEngineeringen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Nuclear Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, U.S.A.en_US
dc.identifier.pmid2613523en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/28222/1/0000675.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0883-2897(89)90138-4en_US
dc.identifier.sourceInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.